How Many Deaths From Vaping Were Confirmed in 2025

Key Facts Upfront

As of mid-2025, public health agencies in the United States and many other countries have not reported a notable increase in confirmed vaping-related deaths compared with recent prior years. Most verified deaths associated with vaping involve THC-containing products, illicit vitamin E acetate exposure, or products obtained outside regulated markets. In the U.S., reports such as those from the CDC indicate zero or only a small number of confirmed vaping-associated deaths in 2025, consistent with patterns seen in recent annual summaries. When serious lung injury is linked to vaping, it is typically acute vaping-associated lung injury (VALI), often tied to illicit market e-liquids or contamination rather than nicotine products from regulated sources.

How Public Health Agencies Track Vaping Deaths

Health authorities use standardized case definitions and systematic reporting to determine whether a death is vaping-related. This process affects the counts you see in official data.

Case Definitions and Criteria

Agencies such as the U.S. Centers for Disease Control and Prevention (CDC) define a case as likely vaping-associated lung injury when all of the following are met:

No alternative plausible cause for the lung injury
Clinical criteria consistent with VALI
A history of vaping within 90 days before symptom onset
No infectious cause that fully explains the illness

Death is attributed to vaping when VALI or another vaping-related condition is the primary cause and no other definitive explanation is found. Investigations often involve state health departments, the CDC, and, when possible, peer review of clinical details to reduce misclassification.

Data Sources and Reporting Timelines

Key systems used to monitor vaping-related harms include:

National Notifiable Diseases Surveillance System (NNDSS): Standardizes reporting across jurisdictions
CDC’s VaD RRT (Vaping-associated lung Injury Rapid Response Team): Reviews complex cases
State health department dashboards: Provide jurisdiction-level counts and updates
National Electronic Injury Surveillance System–Cooperative Adverse Event Surveillance (NEISS-CAD): Tracks emergency department visits linked to vaping

Because thorough investigations can take months, final numbers for a given year are often published with a lag. Preliminary counts may be revised as more information becomes available.

Reputable sources report limited evidence of new vaping-specific deaths in 2025 at the national level in major regulated markets. Context matters: many cases initially flagged as vaping-related are later found to involve illicit THC products, drug interactions, or other comorbidities. The absence of a large, sharp increase in verified deaths does not mean vaping is risk-free; it reflects ongoing patterns observed since e-cigarette regulation tightened in many regions.

2024: frequent in lung samples linked to severe injury 2025: infrequent in regulated markets; more common in illicit samples Environmental and forensic analyses

Metric	2024 (Reported)	2025 (Reported, Mid-Year)	Source / Notes
Confirmed vaping-associated deaths (U.S.)	0–5 under investigation; no large verified cluster	0–3 under investigation; no large verified cluster	CDC, state health department summaries
Reported VALI cases (U.S., NEISS-CAD)	Stable or slightly declining	Stable or slightly declining	Emergency department surveillance
Illicit THC product involvement	Majority of severe outcomes	Majority of severe outcomes	Investigational reports
Vitamin E acetate detections

What Increases the Risk of Severe Outcomes from Vaping

Not all vaping products carry the same risk profile. The main documented drivers of severe harm are product composition, usage patterns, and source of product.

THC and cannabis-containing products obtained outside state-legal, regulated markets
E-liquids modified by users (DIY), especially with undissolved substances such as vitamin E acetate
Products containing nicotine salts at very high concentrations, which may increase addiction potential but are less directly linked to severe lung injury compared with illicit THC
Counterfeit or unregulated devices and refill pods with unknown chemistry

User Behavior and Vulnerability Factors

Young age and nicotine dependence, which can delay recognition of early symptoms
Concurrent use of combustible cigarettes or other drugs, which may worsen respiratory outcomes
Delayed healthcare-seeking when respiratory symptoms develop

Common Misinterpretations of Vaping Death Counts

Public discussions about “vaping deaths” can be confusing because terms like “linked to vaping” are used differently by officials, media, and social platforms.

Correlation Versus Causation

Finding that a person vaped before dying does not automatically mean vaping caused the death. Investigations must rule out other plausible contributors such as underlying lung disease, infections, or drug use. In some high-profile cases, later reviews reclassified causes of death after toxicology and more thorough review.

Legal vs Illicit Markets

Most regulated nicotine-vapor products in many countries have not been associated with widespread severe lung injury or death. The majority of serious outcomes in global reports involve illicit THC cartridges or oils, often containing vitamin E acetate or other unapproved additives. Focusing solely on nicotine vaping can obscure the role of contamination and illicit substances.

Reporting Lags and Revisions

Early news mentions or social posts about vaping deaths are sometimes updated or corrected as agencies complete investigations. Public dashboards may initially list a case as “under investigation” and later reclassify it. This is part of standard public health practice, not a sign of unreliable data.

Global Perspective and Regulation Context

Approaches to vaping regulation shape both product availability and the patterns of harm that emerge. Countries that restrict illicit THC markets and enforce product standards tend to report fewer severe outcomes from regulated nicotine products.

United States Approach

U.S. regulators have pursued premarket authorization for combustible-cigarette-substitute vape products, enforced limits on certain flavors, and cracked down on cartridge-based THC products outside state systems. These measures contributed to declines in youth vaping and stabilized patterns of severe illness, with most remaining severe cases tied to illicit THC.

European and Other Jurisdictions

Many European countries regulate vaping products under tobacco or medical-product frameworks, limiting the concentration of nicotine and requiring ingredient disclosure. In these settings, reports of severe lung injury and death remain rare and are typically associated with non-compliant products or co-use with other substances.

Practical Takeaways for the Public

Understanding how vaping-related deaths are identified and reported can help you interpret headlines and make informed choices.

What This Means for You

Regulated nicotine vaping products are not risk-free, but severe outcomes are rare and most often connected to illicit substances
If you vape, avoid illicit THC products and any e-liquids with unknown ingredients; do not add substances to your device
If you experience respiratory symptoms such as cough, shortness of breath, or chest pain after vaping, seek medical care promptly and mention your vaping history
Public health agencies update data as investigations conclude; changes in counts over time are normal and reflect improved understanding

Bottom Line

Available data through mid-2025 show no large, verified increase in confirmed vaping-related deaths in major regulated markets. Most serious outcomes continue to be associated with illicit THC products, unregulated additives such as vitamin E acetate, and products obtained outside official channels. Public health surveillance is ongoing, and case definitions emphasize rigorous verification to avoid misattribution. For the most current counts and case details, consult official health department dashboards and CDC updates rather than preliminary social reports.